Overview

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Status:
Completed
Trial end date:
2019-06-07
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of high-dose rosuvastatin combined with telmisartan or amlodipine on glucose metabolism in ASCVD patients with impaired fasting glucose and hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Yuhan Corporation
Treatments:
Amlodipine
Rosuvastatin Calcium
Telmisartan